More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...

APPLIN: After nearly 20 years in HIV care, I’ve seen that HIV follows people through every season of life. When life is stable, patients stay in care and maintain suppression, but when challenges ...

Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie recently updated its clinical study titled A Phase 2, Multicenter, ...

The NIH funding will help address a "traditional barrier" to health care, says Elizabeth Evans, professor of community health ...

Gilead stock slumped late Thursday on soft product sales and lighter-than-expected revenue from its newcomer HIV prevention ...

B/F/TAF shows lower ART switching rates and higher persistence among HIV patients, especially those with mental health or ...

The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in 2023. This is despite growing availability of a highly effective HIV ...

More than 230 people became infected with HIV in Indiana, worsened by delayed action from former Gov. Mike Pence. Experts and ...

"You know, it's not the best news. But there was other news that could have been a lot worse, you know?" Charlie Sheen said.

People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer ...